• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines

Recent Advances in the Study of (4-methoxyphenyl)methyl(propyl)amine (CAS: 90390-02-6): A Comprehensive Research Brief

The compound (4-methoxyphenyl)methyl(propyl)amine (CAS: 90390-02-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features, has been the subject of various studies aimed at exploring its potential therapeutic applications and pharmacological properties. The latest research has focused on its synthesis, mechanism of action, and potential as a lead compound in drug development.

Recent studies have demonstrated that (4-methoxyphenyl)methyl(propyl)amine exhibits promising activity in modulating specific neurotransmitter systems, particularly those involving serotonin and dopamine receptors. This has led to investigations into its potential use in treating neurological and psychiatric disorders, such as depression, anxiety, and Parkinson's disease. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to elucidate its molecular structure and interactions with biological targets.

In addition to its neurological applications, (4-methoxyphenyl)methyl(propyl)amine has shown potential in cancer research. Preliminary in vitro studies suggest that it may possess cytotoxic properties against certain cancer cell lines, making it a candidate for further exploration in oncology. Researchers have also investigated its pharmacokinetic profile, including absorption, distribution, metabolism, and excretion (ADME), to better understand its behavior in biological systems.

The synthesis of (4-methoxyphenyl)methyl(propyl)amine has been optimized in recent studies to improve yield and purity. Novel synthetic routes have been developed, leveraging green chemistry principles to minimize environmental impact. These advancements are critical for scaling up production for preclinical and clinical studies. Furthermore, computational modeling has been utilized to predict its binding affinity and selectivity for various receptors, aiding in the design of more potent and selective derivatives.

Despite these promising findings, challenges remain in the development of (4-methoxyphenyl)methyl(propyl)amine as a therapeutic agent. Issues such as bioavailability, potential side effects, and long-term safety need to be addressed through rigorous preclinical and clinical testing. Collaborative efforts between academic institutions and pharmaceutical companies are essential to advance this research and translate findings into viable treatments.

In conclusion, (4-methoxyphenyl)methyl(propyl)amine (CAS: 90390-02-6) represents a compound of significant interest in chemical biology and pharmaceutical research. Its diverse pharmacological properties and potential therapeutic applications make it a valuable subject for ongoing and future studies. Continued research efforts will be crucial in unlocking its full potential and addressing the challenges associated with its development.

• 3910-58-5(N-Butyl-p-methoxy-benzylamine)
• 70894-71-2(N-[(4-methoxyphenyl)methyl]cyclopropanamine)
• 14429-02-8(Benzyl-(4-methoxy-benzyl)-amine)
• 764651-75-4(N-(3-methoxybenzyl)-1-propanamine Hydrochloride)
• 17061-62-0(N,N-Bis(4-methoxybenzyl)amine)
• 60509-46-8(N-(3-Methoxybenzyl)-1-butanamine Hydrochloride)
• 22993-76-6(N-Ethyl-4-methoxybenzenemethanamine)
• 625437-49-2(N-(2-methoxyphenyl)methylcyclopropanamine)
• 893576-11-9(N-(3-Methoxybenzyl)-2-methyl-1-propanamine Hydrochloride)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)